Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Radiation Fibrosis Syndrome 1Precancerous Conditions 1Peripheral Nervous System Diseases 1Melanoma 1Lung Neoplasms 1Glioblastoma 1Edema 1Atrial Fibrillation 1

Interventions

Acupuncture Therapy 4Paclitaxel 3Exercise 3Duloxetine Hydrochloride 3Surveys and Questionnaires 2Physical Therapy Modalities 2Glutamine 2Acetylcysteine 2ziconotide 1sagopilone 1nabilone 1glutamic acid diethyl ester 1eribulin 1allantoicase 1Yoga 1Vitamin B Complex 1Ultrasonic Therapy 1Trimetazidine 1Thioctic Acid 1Therapeutic Touch 1Tadalafil 1Sugars 1Sodium Chloride 1Sirolimus 1Saline Solution 1Prednisolone 1Pentoxifylline 1Pain Management 1Omeprazole 1Omacor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Peripheral Nervous System Diseases × Losartan × Clear all
NCT06135493 2025-04-24

Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients

Future University in Egypt

Phase 2 Completed
84 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡